No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1179 |
4. Check minimum number of eventsNone |
1179 |
5. Include endpointsNone |
1179 |
6. Filter based on genotype QC (FinnGen only) |
1179 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D14
- Name in latin
- Neoplasma benignum laryngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Larynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Larynx
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7637 | 2657 | 4895 |
| Only index persons | 6316 | 2327 | 3989 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.08 | 0.14 |
| Only index persons | 0.13 | 0.09 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 55.93 | 55.72 | 55.94 |
| Only index persons | 54.31 | 54.47 | 54.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1179 | 386 | 793 |
| Unadjusted period prevalence (%) | 0.28 | 0.13 | 0.35 |
| Median age at first event (years) | 56.07 | 52.05 | 58.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1075
- Matched controls
- 10751
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
+∞
323.0
907
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
228.5
323.0
411
29
UDQ22
NOMESCO Finland
Microlaryngoscopy
192.9
260.3
263
18
UDQ12
NOMESCO Finland
Flexible laryngoscopy
17.7
189.1
313
244
DQA10
NOMESCO Finland
Biopsy of larynx
238.1
178.1
179
9
ZXC10
NOMESCO Finland
Use of laser
26.7
134.3
189
85
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
129.5
128.4
136
12
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
136.1
114.7
121
10
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
+∞
111.4
105
*
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
210.1
110.8
113
6
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
+∞
104.9
99
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
41.4
99.7
125
34
1420
FHL
Laryngomicroscopy
50.9
94.7
114
25
J37.0
ICD-10 Finland
Chronic laryngitis
15.2
91.0
156
119
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
41.8
84.8
106
28
UDQ02
NOMESCO Finland
Direct laryngoscopy
43.5
71.0
88
22
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
120.8
63.6
68
6
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
120.2
53.3
57
5
UJC01
NOMESCO Finland
Scopy of lower throat
19.8
50.0
76
41
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
45.3
45.8
56
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
41.3
381
1842
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
40.2
282
1149
R49.0
ICD-10 Finland
Dysphonia
15.2
39.5
66
46
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
106.5
38.0
41
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.7
37.3
137
327
WX734
NOMESCO Finland
JET-ventilation
369.1
36.2
36
*
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
191.3
36.0
37
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
186.0
35.0
36
*
R49.08
ICD-10 Finland
Other specified dysphonia
11.7
34.6
65
59
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.3
34.5
69
71
B977, D141
ICD-10 Finland
NA
+∞
33.5
32
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
17.8
32.6
51
30
DQB30
NOMESCO Finland
Laryngectomy
+∞
32.5
31
*
A02BC05
ATC
esomeprazole; systemic
2.2
31.5
480
2891
J38.7
ICD-10 Finland
Other diseases of larynx
164.7
30.8
32
*
R49.01
ICD-10 Finland
Functional dysphonia
7.9
30.5
71
95
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
30.3
156
501
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
19.2
30.3
46
25
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
29.3
106
248
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
143.6
26.7
28
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.0
25.4
51
53
DQB70
NOMESCO Finland
Total excision of vocal cord
127.8
23.7
25
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.2
23.2
130
441
R13
ICD-10 Finland
Dysphagia
3.6
23.2
112
340
J38.2
ICD-10 Finland
Nodules of vocal cords
26.5
22.7
31
12
A02BC02
ATC
pantoprazole; systemic
1.9
22.4
697
5276
H02AB06
ATC
prednisolone; systemic
1.8
19.6
516
3610
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
18.9
173
789
GB3AV
NOMESCO Finland
NA
101.8
18.6
20
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.8
18.0
41
54
R07.0
ICD-10 Finland
Pain in throat
3.5
17.7
84
251
WX402
NOMESCO Finland
General anaesthesia
2.2
17.6
192
952
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.3
17.5
65
157
UJC02
NOMESCO Finland
Rigid oesophagoscopy
8.3
16.9
37
46
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
91.5
16.6
18
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.2
16.2
39
56
WF002
NOMESCO Finland
Radical radiotherapy
3.2
16.2
89
298
GBB00
NOMESCO Finland
Tracheostomy
7.1
16.0
39
57
R49.09
ICD-10 Finland
Unspecified dysphonia
11.0
15.5
29
27
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
10.6
15.3
29
28
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.0
326
2094
1430
FHL
Laryngoscopy (direct)
57.5
14.8
17
*
A02BC03
ATC
lansoprazole; oral
1.8
14.8
316
2018
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
151.9
14.5
15
*
4509
FHL
Other measure in this category
151.9
14.5
15
*
R03BB04
ATC
tiotropium bromide; inhalant
2.2
13.9
145
698
R03AC02
ATC
salbutamol; inhalant
1.6
13.8
508
3787
J01DA01
ATC
[U] cefalexin; systemic
1.6
13.8
645
5131
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
12.9
489
3653
J01AA02
ATC
doxycycline; systemic
1.7
12.6
786
6665
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
12.2
105
460
130
Kela drug reimbursment
Malignant tumour
2.2
11.9
121
576
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.8
11.9
77
288
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.8
463
3462
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
30.4
11.7
15
5
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
+∞
11.5
11
*
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
121.2
11.4
12
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
11.2
56
176
A02BC01
ATC
omeprazole; systemic
1.7
11.2
292
1951
N07BA03
ATC
varenicline; oral
3.0
11.0
63
217
GBB13
NOMESCO Finland
Revision of tracheostomy
43.8
10.9
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.1
10.9
29
49
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
10.9
160
889
UJF32
NOMESCO Finland
Coloscopy
1.7
10.8
270
1781
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
10.8
78
310
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.3
10.8
32
62
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
10.8
333
2328
R06.0
ICD-10 Finland
Dyspnoea
1.7
10.6
252
1639
N02AA05
ATC
oxycodone; systemic
1.9
10.6
170
974
ENA10
NOMESCO Finland
Biopsy of pharynx
16.2
10.4
16
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.3
278
1871
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.9
10.3
21
24
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
23.6
10.3
14
6
UDC00
NOMESCO Finland
Ear microscopy
2.4
10.2
87
382
A07AA02
ATC
nystatin; oral
2.5
10.1
78
325
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.0
372
2716
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
40.4
10.0
12
*
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
16.9
9.9
15
9
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
9.8
218
1386
Z50.5
ICD-10 Finland
Speech therapy
5.6
9.7
27
49
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
13.5
9.7
16
12
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
100.9
9.4
10
*
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
30.3
9.4
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
9.3
205
1295
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.0
9.3
54
189
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.2
169
1009
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.2
312
2217
H02AB04
ATC
methylprednisolone; systemic
1.9
9.1
148
849
ZXB10
NOMESCO Finland
Medial
6.9
8.9
21
31
R23
ICPC
Voice symptom/complaint
5.2
8.8
26
51
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
7.3
8.8
20
28
ZXA05
NOMESCO Finland
Left side
1.6
8.7
260
1788
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.6
212
1384
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
8.6
72
315
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.5
8.3
64
267
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.2
8.3
80
374
J02AC01
ATC
fluconazole; systemic
1.5
8.0
303
2195
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
6.6
7.9
19
29
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
7.9
107
574
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
10.9
7.8
14
13
R21
ICPC
Throat symptom/complaint
1.8
7.8
145
869
J38.4
ICD-10 Finland
Oedema of larynx
15.1
7.7
12
8
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.6
7.7
21
38
J01FA10
ATC
azithromycin; systemic
1.4
7.7
495
4003
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.6
192
1256
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.6
186
1211
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.6
166
1046
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.2
7.6
19
31
R95
ICPC
Chron obstructive pulmonary disease
3.0
7.5
41
140
N05BA01
ATC
diazepam; systemic, rectal
1.8
7.5
136
809
J01DB01
ATC
cefalexin; oral
1.5
7.4
789
7002
J20
ICD-10 Finland
Acute bronchitis
2.0
7.4
88
451
A02BA02
ATC
ranitidine; systemic
1.6
7.4
204
1367
J01CA04
ATC
amoxicillin; systemic
1.5
7.3
754
6639
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
7.3
204
1373
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
6.3
7.3
18
29
R03BA05
ATC
fluticasone; inhalant
1.7
7.2
162
1028
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
30.2
7.2
9
*
ZXA10
NOMESCO Finland
Bilateral
1.6
7.2
180
1179
J01FA06
ATC
roxithromycin; oral
1.4
7.1
370
2857
J39.2
ICD-10 Finland
Other diseases of pharynx
5.7
7.1
19
34
J01MA12
ATC
levofloxacin; systemic
1.6
7.0
196
1319
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.0
6.9
38
131
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.8
6.9
21
44
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
6.9
99
545
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.8
836
7553
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.8
362
2799
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.4
6.8
19
36
R04.2
ICD-10 Finland
Haemoptysis
2.5
6.8
49
200
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
40.3
6.8
8
*
C320, 8077, 2
ICD-O-3
NA
40.3
6.8
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.7
416
3315
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.7
856
7778
R4130
NOMESCO Finland
Speech therapy
3.2
6.7
32
101
J04.0
ICD-10 Finland
Acute laryngitis
3.5
6.6
29
85
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
12.3
6.6
11
9
UGB02
NOMESCO Finland
Tracheoscopy
12.3
6.6
11
9
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
8.8
6.6
13
15
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
6.6
55
240
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
6.5
79
409
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.5
634
5461
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
70.2
6.4
7
*
J38.6
ICD-10 Finland
Stenosis of larynx
70.2
6.4
7
*
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.4
329
2527
H02AB07
ATC
prednisone; oral
1.7
6.4
145
921
M02AA07
ATC
piroxicam; topical
1.4
6.3
343
2657
UJC12
NOMESCO Finland
Flexible oesophagoscopy
6.0
6.3
16
27
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
6.3
41
157
UGC02
NOMESCO Finland
Rigid bronchoscopy
18.1
6.3
9
5
DQB00
NOMESCO Finland
Excision of lesion of larynx
+∞
6.3
6
*
D14.2
ICD-10 Finland
Benign neoplasm: Trachea
+∞
6.3
6
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
6.2
131
815
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
5.8
6.2
16
28
M54.5
ICD-10 Finland
Low back pain
1.5
6.1
272
2027
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.1
178
1208
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
222
1354
1.79
12.58
20.2
25.9
1.3
1.4
inr
0.10
52
188
247
1570
1.73
12.08
4.5
3.6
0.8
0.8
mmol/l
2.01
237
1468
644
5212
1.52
11.05
8.8
9.3
4.3
4.2
e9/l
0.21
572
4528
521
4059
1.51
10.55
4.7
5.2
34.8
35.0
g/l
0.36
481
3787
821
7083
1.52
9.76
8.6
7.8
82.9
80.0
u/l
0.36
775
6636
601
4898
1.46
9.30
6.6
6.6
12.6
12.1
umol/l
0.17
570
4652
453
3515
1.47
8.93
3.7
3.4
—
—
—
0
0
669
5614
1.44
8.57
5.0
5.2
6.6
6.8
mmol/l
1.70
650
5279
287
2057
1.52
8.25
2.9
2.6
4.1
4.5
e6/l
0.25
241
1810
77
383
2.08
7.99
2.5
2.9
—
—
—
0
0
40
149
2.74
7.89
1.1
1.1
—
—
—
0
0
530
4311
1.42
7.79
4.5
4.1
—
—
—
0
0
695
5960
1.40
7.35
5.4
4.4
369.1
1482.3
e6/l
0.70
14
96
563
4670
1.39
7.18
6.7
7.2
1.2
1.2
mmol/l
0.17
467
3938
744
6474
1.40
7.10
4.2
3.6
15.0
14.8
pmol/l
0.78
666
5805
764
6681
1.41
7.07
4.8
4.0
13.6
12.8
mm/h
0.77
715
6132
233
1653
1.51
6.91
2.1
1.9
—
—
—
0
0
519
4298
1.37
6.46
5.7
6.4
1.2
1.2
mmol/l
0.30
483
3896
345
2670
1.41
6.45
3.4
3.3
0.3
0.5
e6/l
1.80
257
2041
151
1005
1.58
5.95
4.6
3.7
—
—
—
0
0
369
2924
1.38
5.91
2.8
2.6
55.9
56.7
u/l
0.17
342
2708
593
5060
1.35
5.89
2.9
2.7
—
—
—
0
0
469
3865
1.35
5.85
2.0
2.0
95.6
93.5
pmol/l
0.44
254
2049
71
392
1.86
5.54
2.2
1.9
—
—
—
0
0
306
2376
1.39
5.48
2.3
2.1
3.0
3.1
mg/l
0.11
273
2021
877
8018
1.37
5.10
5.2
4.4
2.1
2.1
mu/l
0.13
800
7242
39
181
2.19
4.92
1.1
1.2
—
36.0
—
0
5
43
208
2.11
4.89
1.3
1.2
—
—
—
0
0
379
3092
1.33
4.85
3.2
3.5
2.4
2.3
mmol/l
0.21
334
2691
249
1908
1.39
4.77
4.1
4.0
315.7
330.7
ng/l
0.05
191
1570
230
1741
1.40
4.73
2.7
3.2
2.5
2.4
mmol/l
1.11
200
1532
963
9015
1.37
4.23
20.1
15.9
24.7
26.5
mg/l
1.00
836
7269
159
1150
1.44
4.21
2.1
2.6
1.8
1.8
%
0.26
148
1036
62
362
1.75
4.09
2.3
1.7
—
—
—
0
0
103
689
1.54
4.00
5.7
3.8
5.3
5.1
kpa
1.27
96
643
24
100
2.43
3.91
1.9
1.3
—
—
—
0
0
43
228
1.92
3.87
1.6
1.5
—
—
—
0
0
149
1085
1.43
3.81
2.5
2.9
11.7
8.9
umol/l
0.27
130
969
97
649
1.54
3.77
5.6
3.8
2.0
1.8
mmol/l
0.17
81
487
90
593
1.56
3.75
6.5
8.8
25.5
24.8
mmol/l
1.29
90
588
433
3702
1.27
3.68
3.0
2.8
156.0
155.2
ug/l
0.01
410
3388
347
2893
1.28
3.61
2.4
2.2
194.1
247.9
u/l
0.76
332
2720
125
892
1.45
3.57
3.0
2.6
5.0
7.2
ug/l
1.44
115
787
282
2294
1.30
3.54
2.4
2.4
—
—
—
0
0
34
172
2.01
3.51
3.5
3.2
4.4
4.5
e9/l
0.10
34
172
35
180
1.97
3.46
3.8
3.5
60.2
57.7
%
0.52
35
180
211
1659
1.33
3.37
2.9
2.9
0.9
0.9
e6/l
0.13
119
981
230
1834
1.32
3.33
1.7
1.8
1261.1
1158.6
nmol/l
0.82
182
1364
991
9404
1.34
3.31
21.6
18.5
139.5
139.7
mmol/l
1.56
975
9157
31
156
2.01
3.27
1.8
3.7
2.0
1.4
%
0.30
21
130
182
1410
1.34
3.21
2.2
2.5
2.4
2.3
g/l
1.15
176
1318
200
1574
1.33
3.17
3.2
3.1
1.8
1.4
e6/l
0.32
109
902
1006
9591
1.33
3.06
12.0
10.8
27.5
27.4
u/l
0.03
978
9237
990
9426
1.31
2.97
21.8
18.7
4.0
4.0
mmol/l
0.31
974
9170
157
1205
1.35
2.95
1.7
1.4
—
—
—
0
0
179
1401
1.33
2.95
1.2
1.3
49.4
35.9
iu/ml
0.29
54
438
192
1520
1.31
2.92
2.2
2.6
11.9
13.0
umol/l
1.24
182
1418
500
4430
1.22
2.91
3.8
3.6
0.0
0.0
estimate
0.50
103
784
244
1996
1.28
2.89
1.7
1.7
0.9
1.3
mg/l
3.38
193
1561
493
4367
1.22
2.86
4.7
4.8
0.0
0.0
estimate
0.00
106
827
191
1517
1.31
2.83
1.8
2.1
29.6
30.0
s
0.37
185
1468
169
1324
1.32
2.77
5.0
6.1
1.0
1.0
mmol/l
0.18
157
1224
169
1325
1.32
2.75
2.3
2.6
21.4
23.2
%
0.83
149
1142
286
2400
1.25
2.73
4.3
4.0
0.0
0.0
estimate
0.69
101
790
402
3501
1.22
2.73
2.2
2.2
75.7
76.2
nmol/l
0.14
369
3094
115
857
1.38
2.61
3.3
3.0
412.0
218.5
ng/l
0.49
104
775
344
2960
1.23
2.60
3.3
3.1
1172.4
1712.4
ng/l
2.66
299
2537
429
3781
1.21
2.55
4.8
3.8
43.4
57.5
ng/l
0.45
317
2770
899
8510
1.24
2.50
17.4
14.6
80.2
78.6
ml/min/173m2
1.36
781
7054
45
279
1.64
2.49
4.8
3.1
25.5
24.7
mmol/l
0.55
37
242
152
1192
1.32
2.48
5.7
8.3
5.2
5.1
kpa
0.12
147
1143
9
26
3.48
2.48
1.4
1.0
—
—
—
0
0
490
4383
1.20
2.47
3.7
3.6
0.0
0.0
estimate
0.00
105
815
152
1193
1.31
2.47
5.7
8.2
12.1
11.9
kpa
0.16
146
1147
121
919
1.35
2.45
5.0
7.8
1.5
1.4
mmol/l
0.04
114
885
860
8119
1.22
2.37
16.9
16.9
39.9
40.1
%
0.14
572
5617
151
1192
1.31
2.36
5.7
8.3
1.4
1.2
mmol/l
0.36
121
929
344
2995
1.21
2.28
3.7
3.5
30.1
35.0
u/l
2.13
326
2848
166
1343
1.27
2.16
1.2
1.2
17.3
10.9
u/ml
0.32
52
497
40
254
1.59
2.06
1.2
1.6
—
—
—
0
0
80
587
1.39
2.04
1.6
1.4
—
—
—
0
0
18
90
2.02
2.01
1.9
1.9
—
—
—
0
0
65
464
1.42
1.95
1.5
1.9
1.7
1.5
g/l
1.07
55
410
8
27
2.98
1.94
2.5
2.4
—
—
—
0
0
84
628
1.36
1.93
2.0
1.6
—
—
—
0
0
636
5903
1.17
1.92
3.8
3.3
65.0
55.8
u/l
0.68
591
5486
29
173
1.69
1.91
2.0
1.6
—
—
—
0
0
145
1182
1.26
1.79
2.2
1.8
—
—
—
0
0
145
1184
1.26
1.77
2.2
1.9
—
—
—
0
0
96
744
1.32
1.76
3.2
2.9
82.2
65.5
ml/min/173m2
0.64
43
307
60
432
1.41
1.74
1.8
2.0
3.1
2.0
ug/l
0.31
54
385
295
2593
1.18
1.72
3.0
2.9
5038.7
6049.0
umol/l
0.14
253
2239
13
61
2.14
1.72
1.1
1.3
—
—
—
0
0
18
96
1.89
1.71
1.9
3.9
63.1
53.2
%
1.08
11
70
25
149
1.69
1.67
2.2
1.7
—
—
—
0
0
22
127
1.75
1.65
4.3
2.2
384.1
8002.8
u/l
—
9
38
38
253
1.52
1.64
1.9
1.7
—
—
—
0
0
117
941
1.27
1.63
3.2
3.9
1.9
2.0
mmol/l
0.01
99
743
25
151
1.67
1.60
1.7
1.5
—
—
—
0
0
1028
9986
1.23
1.60
28.1
22.8
246.0
242.0
e9/l
1.03
1009
9707
1028
9990
1.23
1.57
28.0
22.8
4.5
4.5
e12/l
1.42
1005
9682
23
137
1.69
1.56
2.1
1.6
—
—
—
0
0
1028
9992
1.23
1.55
28.2
23.0
135.0
136.3
g/l
1.89
1016
9821
0
42
0.00
1.52
0.0
2.2
—
52.6
—
0
34
32
210
1.54
1.49
3.7
2.7
15.7
16.0
%
0.11
15
110
202
1742
1.19
1.47
1.3
1.2
1.3
1.4
u/ml
0.14
61
462
23
141
1.64
1.42
1.0
1.3
—
—
—
0
0
115
942
1.24
1.40
3.1
3.9
5.8
5.9
kpa
0.08
109
915
115
942
1.24
1.40
6.9
7.8
9.5
10.3
mmol/l
0.71
109
898
50
365
1.39
1.39
1.0
1.1
—
—
—
0
0
9
41
2.20
1.37
3.7
4.0
—
—
—
0
0
915
8830
1.16
1.36
5.2
4.7
6.1
6.1
mmol/l
0.08
831
7985
0
38
0.00
1.34
0.0
1.0
—
—
—
0
0
113
929
1.24
1.34
2.9
2.3
0.2
0.2
g/l
0.82
108
863
22
136
1.63
1.33
1.9
1.6
—
—
—
0
0
772
7371
1.14
1.31
20.9
19.2
13.9
13.8
%
1.90
762
7206
38
267
1.44
1.31
2.2
2.5
110.5
103.1
ug/min
0.05
20
161
371
3384
1.14
1.30
4.1
3.8
—
—
—
0
0
19
114
1.68
1.28
2.5
1.8
—
—
—
0
0
37
260
1.44
1.28
1.1
1.2
—
—
—
0
0
151
1288
1.20
1.25
5.4
7.4
104.3
104.2
mmol/l
0.07
146
1256
92
748
1.25
1.22
4.8
3.9
1.2
1.2
mmol/l
0.75
85
651
108
894
1.23
1.22
2.3
2.5
29.6
37.0
u/l
0.71
80
763
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
876
8454
1.14
1.20
6.6
6.1
40.1
40.4
mmol/mol
0.51
808
7768
18
109
1.66
1.19
7.2
4.4
—
—
—
0
0
14
79
1.78
1.17
2.3
1.6
—
—
—
0
0
34
240
1.43
1.17
2.0
1.7
—
—
—
0
0
39
286
1.38
1.10
1.6
1.7
—
—
—
0
0
25
169
1.49
1.07
1.2
1.1
—
—
—
0
0
36
262
1.39
1.06
1.1
1.2
—
—
—
0
0
89
734
1.23
1.06
1.9
1.6
—
—
—
0
0
5
22
2.28
1.03
1.4
1.5
—
—
—
0
0
11
60
1.84
1.03
1.0
1.2
10.4
12.9
mmol/l
—
6
21
5
23
2.18
0.98
3.2
3.1
—
—
—
0
0
25
173
1.45
0.98
2.2
1.8
—
—
—
0
0
9
50
1.81
0.96
2.8
1.6
—
—
—
0
0
328
3022
1.12
0.96
3.9
3.2
7.4
7.9
mmol/l
1.36
275
2492
0
31
0.00
0.96
0.0
3.9
—
71.8
—
0
26
7
37
1.90
0.94
1.4
2.7
170.7
214.0
u/l
—
7
37
6
27
2.23
0.93
1.8
1.8
—
—
—
0
0
13
78
1.67
0.91
1.4
1.4
—
—
—
0
0
41
314
1.32
0.91
2.3
1.8
32.2
40.1
nmol/l
2.65
41
301
17
111
1.54
0.88
1.1
1.1
0.5
1.9
u/ml
—
8
53
8
44
1.82
0.86
1.0
1.1
520.8
250.0
iu/ml
—
8
44
29
213
1.37
0.85
1.3
1.2
1.8
6.1
u/ml
—
5
28
69
571
1.22
0.84
2.1
1.8
—
—
—
0
0
482
4568
1.09
0.79
5.2
4.9
3.1
3.8
ug/l
0.23
430
4069
49
393
1.26
0.79
2.7
2.4
—
—
—
0
0
49
393
1.26
0.79
2.7
2.4
3.6
3.9
g/l
0.97
35
292
49
393
1.26
0.79
2.7
2.4
6.9
7.3
g/l
1.07
36
303
11
66
1.67
0.79
1.2
1.0
0.4
0.4
u/ml
—
5
21
16
107
1.50
0.76
1.3
1.8
—
—
—
0
0
12
76
1.58
0.71
1.5
1.1
—
—
—
0
0
46
372
1.25
0.71
2.8
2.5
2.8
3.1
g/l
1.57
35
295
45
364
1.25
0.70
2.8
2.5
9.8
10.8
g/l
0.78
37
313
15
102
1.48
0.67
1.3
1.8
—
—
—
0
0
7
43
1.63
0.67
2.6
1.7
—
—
—
0
0
79
681
1.17
0.66
2.9
3.9
82.4
93.8
ng/l
0.65
70
599
124
1106
1.14
0.65
2.0
1.9
1.5
1.6
%
0.10
109
946
10
62
1.62
0.65
1.3
1.4
—
—
—
0
0
10
62
1.62
0.65
1.3
1.4
—
—
—
0
0
904
8849
1.09
0.63
4.7
4.5
1.4
1.4
mmol/l
1.97
835
8079
129
1159
1.13
0.61
10.6
7.8
—
—
—
0
0
8
50
1.60
0.61
3.0
1.6
—
—
—
0
0
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
8
52
1.54
0.59
4.1
2.4
—
—
—
0
0
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
927
9093
1.09
0.59
5.3
5.1
2.7
2.7
mmol/l
0.10
855
8296
11
72
1.53
0.59
1.7
2.0
416.7
716.3
e6/l
—
6
27
8
53
1.51
0.58
1.4
1.3
145.3
467.2
u/l
—
8
48
323
3049
1.08
0.57
4.2
4.0
9.1
9.3
mg/mmol
0.02
218
1975
8
55
1.46
0.56
1.4
1.6
—
—
—
0
0
55
468
1.18
0.55
1.9
2.9
0.6
0.7
%
0.97
55
455
13
90
1.45
0.55
1.2
1.3
—
—
—
0
0
23
177
1.31
0.55
1.1
1.1
—
—
—
0
0
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
33
267
1.24
0.54
1.8
1.6
0.1
23.2
iu/ml
—
6
52
9
61
1.48
0.53
2.7
1.5
—
—
—
0
0
103
1147
0.89
0.53
4.8
4.6
31.3
31.6
%
0.10
76
755
22
169
1.31
0.53
1.1
1.1
198.9
287.9
u/ml
1.32
15
100
909
8923
1.08
0.53
4.8
4.6
4.5
4.5
mmol/l
0.14
848
8204
31
250
1.25
0.52
4.9
3.1
36.7
33.9
umol/l
0.26
25
205
16
117
1.37
0.52
1.5
1.5
—
—
—
0
0
10
145
0.69
0.50
1.3
1.6
—
—
—
0
0
13
92
1.42
0.50
1.1
1.3
51.4
52.7
u/l
—
8
67
16
118
1.36
0.50
1.9
2.3
12.2
20.7
mg/l
—
6
24
39
325
1.21
0.50
2.9
3.6
48.7
77.6
mg/l
0.74
29
266
39
325
1.21
0.50
2.9
3.6
26.3
47.6
mg/l
1.39
30
267
27
216
1.26
0.49
3.3
3.1
0.8
0.9
nmol/l
1.01
20
171
7
45
1.56
0.49
1.3
1.3
—
—
—
0
0
7
108
0.65
0.48
1.1
2.0
—
1552.0
—
0
5
215
2012
1.08
0.48
1.7
1.7
56322269.1
28979763.8
pmol/l
0.20
174
1646
92
826
1.12
0.47
2.3
2.7
66.5
66.4
g/l
0.05
84
753
87
780
1.12
0.46
2.5
3.1
4.6
4.5
kpa
0.11
81
754
111
1010
1.11
0.46
3.4
4.3
10.5
26.5
ug/l
0.86
91
847
7
50
1.40
0.45
1.3
1.3
—
—
—
0
0
36
302
1.20
0.44
1.8
1.8
3.8
3.2
mg/l
0.12
21
225
873
8579
1.07
0.44
4.3
4.1
1.4
1.3
mmol/l
2.92
805
7787
27
221
1.23
0.42
1.3
1.4
35.0
26.6
iu/l
0.59
21
193
25
203
1.24
0.42
3.2
3.7
28.8
28.5
mg/l
0.01
17
128
0
16
0.00
0.41
0.0
1.1
—
28.6
—
0
10
74
824
0.89
0.41
1.5
1.4
—
—
—
0
0
8
59
1.36
0.41
1.4
1.2
—
—
—
0
0
71
635
1.13
0.40
2.2
1.9
—
—
—
0
0
25
205
1.22
0.39
3.8
3.8
45.8
1475.6
u/ml
0.64
20
193
15
115
1.31
0.39
1.5
1.5
—
—
—
0
0
54
477
1.14
0.38
1.2
1.2
46.2
141.1
iu/ml
2.77
16
183
9
70
1.29
0.36
1.0
1.8
16.3
19.6
nmol/l
—
9
63
15
117
1.29
0.35
1.5
1.5
—
—
—
0
0
9
124
0.72
0.35
1.0
1.0
—
—
—
0
0
97
892
1.10
0.35
2.4
2.2
11.5
13.2
nmol/l
1.42
84
789
6
45
1.33
0.33
1.2
1.1
—
—
—
0
0
63
697
0.90
0.33
1.9
1.8
—
—
—
0
0
378
3655
1.05
0.32
4.9
4.3
24.0
21.3
%
2.60
170
1771
17
137
1.24
0.32
1.4
1.1
1.6
1.5
g/l
0.04
17
124
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
30
258
1.17
0.31
1.3
1.4
—
—
—
0
0
239
2287
1.06
0.31
1.7
1.6
19.1
20.1
nmol/l
0.46
214
1948
7
53
1.32
0.31
1.9
1.4
—
—
—
0
0
253
2430
1.05
0.29
1.5
1.7
1.4
1.4
mmol/l
0.42
206
2017
255
2652
0.95
0.28
2.9
3.1
0.7
0.8
ug/l
0.61
164
1759
8
62
1.29
0.28
1.1
1.7
—
—
—
0
0
8
62
1.29
0.28
1.1
1.7
—
—
—
0
0
23
196
1.18
0.27
2.0
2.0
—
—
—
0
0
35
309
1.14
0.27
1.2
1.3
—
—
—
0
0
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
14
170
0.82
0.25
1.1
1.4
—
—
—
0
0
28
245
1.15
0.25
2.1
2.0
—
—
—
0
0
43
388
1.11
0.24
1.4
1.3
—
—
—
0
0
6
81
0.74
0.24
1.3
1.5
—
—
—
0
0
11
88
1.25
0.22
1.0
1.2
1.2
1.5
nmol/l
0.89
11
80
18
210
0.85
0.22
3.6
3.4
1.4
1.5
mmol/l
0.38
18
204
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
5
41
1.22
0.22
2.6
2.4
79.0
99.6
%
—
5
41
13
107
1.22
0.21
3.5
2.7
—
—
—
0
0
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
5.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
24
211
1.14
0.20
1.5
1.4
—
—
—
0
0
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
31
279
1.11
0.19
1.7
1.5
265.0
281.9
ug/g
0.17
20
159
14
118
1.19
0.19
1.5
1.5
—
—
—
0
0
14
118
1.19
0.19
1.5
1.5
—
—
—
0
0
35
318
1.10
0.19
3.2
2.4
39.4
37.5
g/l
1.12
30
276
202
1954
1.04
0.19
4.8
4.0
1.0
1.0
kg/l
1.04
30
269
18
156
1.16
0.18
1.5
1.4
—
—
—
0
0
24
213
1.13
0.18
1.3
1.4
11.1
8.0
u/l
0.39
19
173
29
261
1.11
0.18
1.3
1.6
—
—
—
0
0
21
185
1.14
0.18
2.2
1.8
5.7
5.6
iu/l
—
9
54
14
119
1.18
0.17
1.5
1.5
—
—
—
0
0
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
5
67
0.75
0.17
1.0
1.2
—
—
—
0
0
5
67
0.75
0.17
1.0
1.2
—
—
—
0
0
37
340
1.09
0.16
3.2
2.6
1.1
1.4
g/l
0.16
31
301
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
360
1.09
0.16
2.1
2.4
0.3
0.4
u/ml
0.33
22
202
11
92
1.20
0.16
1.1
1.1
—
—
—
0
0
9
78
1.16
0.15
1.0
1.0
—
—
—
0
0
7
88
0.79
0.14
1.1
1.0
—
—
—
0
0
11
93
1.18
0.14
1.1
1.1
—
—
—
0
0
28
256
1.10
0.14
2.5
2.1
9.1
11.8
mg/l
1.23
28
235
17
191
0.89
0.14
1.7
1.5
3038.6
728.7
e6/l
0.65
12
157
17
191
0.89
0.14
1.6
1.4
12.0
52.0
e6/l
0.68
12
152
22
200
1.10
0.12
7.7
6.8
112.0
946.6
iu/ml
—
5
34
18
199
0.90
0.11
3.6
3.5
7.8
7.6
mmol/l
0.19
18
194
51
484
1.06
0.11
5.8
4.3
23.6
24.0
mmol/l
0.34
45
439
22
239
0.92
0.10
1.6
1.6
8771.5
13825.6
e6/l
0.35
15
177
6
56
1.07
0.08
1.0
1.2
83.7
80.3
u/l
—
6
50
5
61
0.82
0.08
1.0
1.3
—
69.0
—
0
10
5
60
0.83
0.08
1.2
1.6
4.2
7.7
u/l
—
5
47
16
146
1.10
0.08
1.0
1.1
9.0
73.4
iu/ml
—
5
31
29
274
1.06
0.07
1.6
1.7
—
—
—
0
0
9
86
1.05
0.07
1.6
1.7
—
—
—
0
0
14
128
1.09
0.06
1.4
1.2
2.3
5.8
u/ml
—
8
57
9
101
0.89
0.06
4.0
2.6
—
—
—
0
0
24
227
1.06
0.06
1.4
1.4
—
—
—
0
0
24
227
1.06
0.06
1.4
1.4
—
—
—
0
0
22
208
1.06
0.05
1.2
1.1
—
—
—
0
0
11
100
1.10
0.05
1.1
1.1
—
—
—
0
0
18
173
1.04
0.01
1.1
1.2
109.8
43.4
u/l
0.54
11
148
25
244
1.03
0.00
1.4
1.3
—
—
—
0
0
12
124
0.97
0.00
1.2
1.1
—
—
—
0
0
13
126
1.03
0.00
1.2
1.1
—
—
—
0
0
27
266
1.02
0.00
1.5
2.0
—
—
—
0
0
10
98
1.02
0.00
1.4
1.2
7.6
7.8
mmol/l
—
10
64
18
177
1.02
0.00
1.3
1.3
285.8
227.9
miu/ml
—
5
77
21
213
0.99
0.00
1.9
1.6
—
—
—
0
0
14
145
0.97
0.00
1.2
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
21
210
1.00
0.00
1.3
1.3
—
—
—
0
0
6
60
1.00
0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
2.0
2.2
—
—
—
0
0
6
63
0.95
0.00
2.5
1.6
—
—
—
0
0
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
6
66
0.91
0.00
1.7
1.7
—
—
—
0
0
5
54
0.93
0.00
2.0
2.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
5
54
0.93
0.00
1.0
1.2
7.4
17.4
u/l
—
5
47
5
54
0.93
0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
10.2
18.3
1465.8
1500.4
nmol/l
—
5
56
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_LARYNX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LARYNX | 1.44 [1.24, 1.67] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.792 |
During the follow-up period (1.1.1998 — 31.12.2019), 365 out of 1646 females with CD2_BENIGN_LARYNX died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LARYNX | 1.766 [1.57, 1.99] | < 0.001 |
| Birth year | 0.985 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 973 out of 3146 males with CD2_BENIGN_LARYNX died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_LARYNX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.172% | 0.328% |
| 5 | 1.02% | 1.903% |
| 10 | 2.305% | 4.549% |
| 15 | 4.399% | 8.697% |
| 20 | 7.596% | 14.442% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LARYNX – Benign neoplasm: Larynx
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data